ad image

Wuxi Advanced Therapies

1 / 1
2021 Roundup: The Year of Cell and Gene Therapy

2021 Roundup: The Year of Cell and Gene Therapy

David Alvaro, Ph.D.

Pharma's Almanac

PA734Dec 20, 2021
Quality and Regulatory Challenges Surrounding New Cell and Gene Therapy Products
Cell and Gene Therapy

Quality and Regulatory Challenges Surrounding New Cell and Gene Therapy Products

Jennifer Cheung

WuXi Advanced Therapies

PAO-09-21-CL-07Sep 14, 2021
Expanding a Comprehensive Platform to Support the Future of Cell and Gene Therapies
Cell and Gene Therapy

Expanding a Comprehensive Platform to Support the Future of Cell and Gene Therapies

David Y. H. Chang, Ph.D.

WuXi Advanced Therapies

PAO-05-21-CL-05May 27, 2021
Increasing Predictability with AAV Platform Technologies
AAV Platform Technologies

Increasing Predictability with AAV Platform Technologies

Felix Hsu

WuXi Advanced Therapies

PAP-Q4-20-CL-027Dec 09, 2020
WuXi AppTec
Capacity Expansion

WuXi Advanced Therapies Expands Philadelphia Campus with New State-of-the-Art Testing Laboratory

WuXi AppTec

PR-M11-20-019Nov 19, 2020
WuXi AppTec
Expanded Services

WuXi Advanced Therapies Expands Services to Include High-Quality and Cost-Effective R&D and GMP Plasmid DNA

WuXi AppTec

PR-M11-20-011Nov 12, 2020
WuXi Advanced Therapies
CAR-T Cell Therapy

WuXi Advanced Therapies Launches New Closed Process CAR-T Cell Therapy Platform

WuXi Advanced Therapies

PR-M05-20-NI-025May 18, 2020
WuXi Advanced Therapies
AAV

WuXi Advanced Therapies Launches New World-Class AAV Vector Suspension Platform

WuXi Advanced Therapies

PR-M01-20-NI-017Jan 13, 2020
WuXi AppTec
Strategic Partnership

TrakCel Announces Strategic Partnership with WuXi AppTec Advanced Therapies for Optimization of Supply Chain for Cell and Gene Therapy Treatments

WuXi AppTec

PR-M10-19-NI-008-2078Oct 01, 2019
Driving Growth of the Cell and Gene Therapy Sector
Cell and Gene Therapy

Driving Growth of the Cell and Gene Therapy Sector

Felix Hsu

WuXi Advanced Therapies

PAP-Q1-2019-CL-012Mar 12, 2019
1 / 1